CI
EXAS

CX Institutional’s Exact Sciences EXAS Stock Holding History

CX Institutional’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12
Closed -$1K – 968
2021
Q2 		$1K Hold
12
– – ﹤0.01% 935
2021
Q1 		$2K Buy
+12
New +$1.64K ﹤0.01% 824
2020
Q1 		– Sell
-200
Closed -$18K – 778
2019
Q4 		$18K Hold
200
– – ﹤0.01% 357
2019
Q3 		$18K Hold
200
– – ﹤0.01% 382
2019
Q2 		$24K Hold
200
– – ﹤0.01% 385
2019
Q1 		$17K Hold
200
– – ﹤0.01% 412
2018
Q4 		$13K Hold
200
– – ﹤0.01% 343
2018
Q3 		$16K Hold
200
– – 0.01% 235
2018
Q2 		$12K Buy
+200
New +$10.8K ﹤0.01% 221

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CX Institutional's EXAS Position: Q3 2021 in Review

CX Institutional sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 12 shares — an estimated $1K sold.

CX Institutional first reported a position in EXAS in Q2 2018 and held it in 9 quarters. The position peaked at $24K in Q2 2019. 601 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • CX Institutional reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
  • CX Institutional sold 12 Exact Sciences shares in Q3 2021, an estimated $1K.
  • CX Institutional first reported a position in Exact Sciences in Q2 2018 and held it in 9 quarters.
  • CX Institutional's Exact Sciences position peaked at $24K in Q2 2019.
  • 601 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on CX Institutional's 13F filing for Q3 2021, filed 10 Nov 2021.